
Class I PI3K inhibitor ZSTK474 attenuates experimental autoimmune neuritis by decreasing the frequency of Th1/Th17 cells and reducing the production of proinflammatory cytokines
Keywords: AUC; area under the curve; CMAP; compound muscle action potential; DAPI; 4â²,6-diamidino-2- phenylindole; dpi; days post-inoculation; EAN; experimental autoimmune neuritis; ELISA; enzyme-linked immunosorbent assay; EMG; electromyography; GAPDH; glycerald